[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 8 of about 8
1. Porzezińska M, Drozdowski J, Poławska K, Wolska-Goszka L, Cynowska B, Słomiński JM: [Isolated sarcoidosis of upper respiratory tract--a description of 2 cases]. Pneumonol Alergol Pol; 2008;76(4):276-80
Hazardous Substances Data Bank. PREDNISONE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In sarcoidosis almost all organs can be involved but the disease most often affects the lungs and intrathoracic lymph nodes.
  • We present two cases of sarcoidosis limited to upper respiratory tract--a young woman with laryngeal sarcoidosis and recurrent throat pain, and a woman with disease of the sinuses and pharynx and clinical symptoms of chronic sinusitis poorly responsive to conventional treatment.
  • [MeSH-major] Laryngeal Diseases / drug therapy. Laryngeal Diseases / radiography. Sarcoidosis / drug therapy. Sarcoidosis / radiography. Sinusitis / drug therapy. Sinusitis / radiography
  • [MeSH-minor] Adult. Anti-Inflammatory Agents / therapeutic use. Diagnosis, Differential. Female. Humans. Middle Aged. Prednisone / therapeutic use. Tomography, X-Ray Computed. Treatment Outcome

  • Genetic Alliance. consumer health - Sarcoidosis.
  • Genetic Alliance. consumer health - Sarcoidosis 2.
  • MedlinePlus Health Information. consumer health - Sarcoidosis.
  • MedlinePlus Health Information. consumer health - Sinusitis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18785133.001).
  • [ISSN] 0867-7077
  • [Journal-full-title] Pneumonologia i alergologia polska
  • [ISO-abbreviation] Pneumonol Alergol Pol
  • [Language] pol
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Poland
  • [Chemical-registry-number] 0 / Anti-Inflammatory Agents; VB0R961HZT / Prednisone
  •  go-up   go-down


2. Gorbunov AV, Kochetkova EIa: [Organization of detection of patients with tuberculosis in Moscow]. Probl Tuberk Bolezn Legk; 2005;(8):18-22
Genetic Alliance. consumer health - Tuberculosis.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The subject of the study was the Moscow population numbering about 7 million people to undergo fluorographic examinations and a group of new cases (more than 12,000) of pulmonary tuberculosis.
  • The study has provided the following data: The most patients with pulmonary tuberculosis are detected in the polyclinics, general somatic and mental hospitals, and psychoneurological nursing homes; they amount to 74.8, 22, and 3.2%, respectively.
  • Next is focal tuberculosis (14.9%); then in the descending order: disseminated tuberculosis (14.6%); tuberculosis of intrathoracic lymph nodes (4.1%); tuberculoma (3.9%), pleuritis (3.3%), caseous pneumonia (2.9%), cavernous and fibrocavernous tuberculosis (1.8%), and cirrhotic tuberculosis (0.5%).
  • In medical risk groups, tuberculosis is more frequently identified in patients with mental diseases, chronic nonspecific respiratory diseases, and alcohol and drug users (8.7, 5.3, and 2.5, respectively per 1000).
  • [MeSH-minor] Adolescent. Adult. Age Factors. Disabled Persons. Employment. Female. Fluoroscopy. Homeless Persons. Humans. Male. Middle Aged. Moscow / epidemiology. Retirement. Risk Factors. Sex Factors. Socioeconomic Factors. Tuberculosis, Lymph Node / radiography

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16209013.001).
  • [ISSN] 1728-2993
  • [Journal-full-title] Problemy tuberkuleza i bolezneĭ legkikh
  • [ISO-abbreviation] Probl Tuberk Bolezn Legk
  • [Language] rus
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Russia (Federation)
  •  go-up   go-down


3. Foley RJ, Metersky ML: Successful treatment of sarcoidosis-associated pulmonary hypertension with bosentan. Respiration; 2008;75(2):211-4
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Sarcoidosis is a systemic granulomatous disease of unknown etiology, in which the lungs and intrathoracic lymph nodes are predominant sites of involvement.
  • [MeSH-major] Antihypertensive Agents / therapeutic use. Endothelin-1 / antagonists & inhibitors. Hypertension, Pulmonary / drug therapy. Sarcoidosis, Pulmonary / complications. Sulfonamides / therapeutic use
  • [MeSH-minor] Hemodynamics / drug effects. Humans. Male. Middle Aged. Respiratory Function Tests

  • Genetic Alliance. consumer health - Pulmonary Hypertension.
  • Genetic Alliance. consumer health - Sarcoidosis.
  • MedlinePlus Health Information. consumer health - Blood Pressure Medicines.
  • MedlinePlus Health Information. consumer health - Pulmonary Hypertension.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright (c) 2008 S. Karger AG, Basel
  • (PMID = 16293957.001).
  • [ISSN] 1423-0356
  • [Journal-full-title] Respiration; international review of thoracic diseases
  • [ISO-abbreviation] Respiration
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Switzerland
  • [Chemical-registry-number] 0 / Antihypertensive Agents; 0 / Endothelin-1; 0 / Sulfonamides; Q326023R30 / bosentan
  •  go-up   go-down


Advertisement
4. Ivanovskiĭ VB, Nasorina RN, Ostroumova OM, Alekseeva DIu, Loshchinskaia NN: [Steroidal leukocytosis and immediate results of treatment in patients with sarcoidosis]. Probl Tuberk Bolezn Legk; 2006;(4):39-41
Hazardous Substances Data Bank. PREDNISONE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The occurrence of steroidal leukocytosis at early stages of an observation may, to a certain extent, serve an objective criterion for predicting the pronounced immediate results of treatment in first detected patients with sarcoidosis (that of intrathoracic lymph nodes and the lung in particular) and thus makes it possible to judge the adequacy of therapy in the inpatient setting.
  • [MeSH-major] Anti-Inflammatory Agents / adverse effects. Leukocytosis / chemically induced. Prednisone / adverse effects. Sarcoidosis, Pulmonary / drug therapy

  • Genetic Alliance. consumer health - Sarcoidosis.
  • MedlinePlus Health Information. consumer health - Steroids.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16813059.001).
  • [ISSN] 1728-2993
  • [Journal-full-title] Problemy tuberkuleza i bolezneĭ legkikh
  • [ISO-abbreviation] Probl Tuberk Bolezn Legk
  • [Language] rus
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Russia (Federation)
  • [Chemical-registry-number] 0 / Anti-Inflammatory Agents; VB0R961HZT / Prednisone
  •  go-up   go-down


5. Ovsiankina ES, Gubkina MF, Kobulashvili MG, Panova LV: [Chemotherapy for tuberculosis in children and adolescents: problems and ways of their solution]. Probl Tuberk Bolezn Legk; 2006;(8):26-9
Genetic Alliance. consumer health - Tuberculosis.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Chemotherapy for tuberculosis in children and adolescents: problems and ways of their solution].
  • The clinical pattern is mainly represented by infiltrative, focal tuberculosis and tuberculosis of intrathoracic lymph nodes (94.5%) and, in single cases, by other forms of tuberculosis.
  • The active application of pathogenetic treatment modalities that promote the acceleration of reparative processes (physiotherapy in particular) generated the necessity of using 3 antituberculous agents in the phase of treatment continuation.
  • [MeSH-major] Antitubercular Agents / therapeutic use. Guidelines as Topic. Tuberculosis, Pulmonary / drug therapy
  • [MeSH-minor] Adolescent. Algorithms. Child. Child, Preschool. Drug Hypersensitivity / epidemiology. Drug Hypersensitivity / etiology. Female. Humans. Male. Severity of Illness Index

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17002054.001).
  • [ISSN] 1728-2993
  • [Journal-full-title] Problemy tuberkuleza i bolezneĭ legkikh
  • [ISO-abbreviation] Probl Tuberk Bolezn Legk
  • [Language] rus
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Russia (Federation)
  • [Chemical-registry-number] 0 / Antitubercular Agents
  •  go-up   go-down


6. Poddubnaia LV, Romanov VV: [Implication of tuberculosis antibodies in the determination of tuberculous infection]. Probl Tuberk Bolezn Legk; 2006;(3):37-40
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The determination of the total level of antibodies to MBT antigens makes it possible to establish the latent activity of tuberculous infection in children, to form high tuberculosis-risk groups, and to select patients for preventive medicine.
  • It is also of value in diagnosing the minor forms of tuberculosis of intrathoracic lymph nodes in children.
  • [MeSH-major] Antibodies, Bacterial / analysis. Mycobacterium tuberculosis / immunology. Tuberculosis / diagnosis
  • [MeSH-minor] Antigens, Bacterial / analysis. Child. Child, Preschool. Diagnosis, Differential. Follow-Up Studies. Humans. Risk Factors

  • Genetic Alliance. consumer health - Tuberculosis.
  • MedlinePlus Health Information. consumer health - Tuberculosis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16817558.001).
  • [ISSN] 1728-2993
  • [Journal-full-title] Problemy tuberkuleza i bolezneĭ legkikh
  • [ISO-abbreviation] Probl Tuberk Bolezn Legk
  • [Language] rus
  • [Publication-type] Comparative Study; English Abstract; Journal Article
  • [Publication-country] Russia (Federation)
  • [Chemical-registry-number] 0 / Antibodies, Bacterial; 0 / Antigens, Bacterial
  •  go-up   go-down


7. Suga K, Yuan Y, Ueda K, Kaneda Y, Kawakami Y, Zaki M, Matsunaga N: Computed tomography lymphography with intrapulmonary injection of iopamidol for sentinel lymph node localization. Invest Radiol; 2004 Jun;39(6):313-24
MedlinePlus Health Information. consumer health - Lung Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Computed tomography lymphography with intrapulmonary injection of iopamidol for sentinel lymph node localization.
  • PURPOSE: Experimental and clinical evaluation of the potential utility of indirect computed tomographic lymphography (CT-LG) with intrapulmonary injection of iopamidol for preoperative localization of sentinel lymph node station in non-small cell lung cancer.
  • METHODS: CT-LG with intrapulmonary injection of 0.5 mL of undiluted iopamidol was performed in 10 dogs using a multidetector-row CT unit, followed by postmortem examination of enhanced lymph nodes in 5 of these dogs.
  • The CT-LG with peritumoral injection of 1 mL of the contrast agent was also performed in 9 patients with non-small cell lung cancer without lymphadenopathy.
  • At surgery, enhanced lymph nodes were resected under CT-LG guide, followed by standard lymph node dissection with macroscopic and histologic examination.
  • A significant enhancement of lymph nodes was determined when CT attenuation value was increased with 30 Hounsfield units (HU) compared with precontrast images.
  • RESULTS: CT-LG visualized a total of 15 enhanced lymph nodes (on average, 1.5 nodes per animal) within 2 minutes after contrast injection in the 10 dogs, with average size of 6.7+/- 1.9 mm and average maximum CT attenuation of 149 +/- 41 HU.
  • All the 8 enhanced nodes in 5 dogs were found in the appropriate anatomic locations in postmortem examinations.
  • Without noticeable complications, CT-LG visualized 30 ipsilateral intrathoracic lymph nodes including 19 hilar/pulmonary and 11 mediastinal nodes in the 9 patients (on average, 2.2 hilar/pulmonary and 1.1 mediastinal nodes per patient) within 2 minutes after contrast injection, with average size of 4.7+/- 0.4 mm and average maximum CT attenuation of 134 +/- 52 HU.
  • At surgery, all these enhanced nodes could be accurately found and resected under CT-LG guidance.
  • Metastasis was not evident in either of these enhanced lymph nodes or the remaining distant nodes in all patients.
  • CONCLUSION: Quick and accurate localization of sentinel lymph node station on detailed underlying lung anatomy by using indirect CT-LG may be of value to guide selective lymph node dissection for minimally invasive surgery in non-small cell lung cancer.
  • [MeSH-major] Carcinoma, Non-Small-Cell Lung / pathology. Contrast Media / administration & dosage. Iopamidol / administration & dosage. Lung Neoplasms / pathology. Lymphography / methods. Tomography, X-Ray Computed / methods
  • [MeSH-minor] Aged. Aged, 80 and over. Animals. Dogs. Female. Humans. Injections. Lung. Lymph Node Excision. Male. Middle Aged. Preoperative Care

  • MedlinePlus Health Information. consumer health - CT Scans.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15167097.001).
  • [ISSN] 0020-9996
  • [Journal-full-title] Investigative radiology
  • [ISO-abbreviation] Invest Radiol
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Contrast Media; JR13W81H44 / Iopamidol
  •  go-up   go-down


8. Kevorkov NN, Gorovits GA, Bakhmet'ev SA: [Likopid in the complex immunomodulating treatment of patients with sarcoidosis of the lung and intrathoracic lymph nodes]. Ter Arkh; 2002;74(3):55-8
MedlinePlus Health Information. consumer health - Sarcoidosis.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Likopid in the complex immunomodulating treatment of patients with sarcoidosis of the lung and intrathoracic lymph nodes].
  • AIM: To examine the functional status of the immune system in patients with lung and intrathoracic lymph nodes sarcoidosis and to evaluate the efficiency of immunomodulation alone and in its inclusion in combined treatment of the disease.
  • [MeSH-major] Acetylmuramyl-Alanyl-Isoglutamine / analogs & derivatives. Acetylmuramyl-Alanyl-Isoglutamine / therapeutic use. Adjuvants, Immunologic / therapeutic use. Lymph Nodes / pathology. Sarcoidosis / drug therapy
  • [MeSH-minor] Adult. Drug Therapy, Combination. Glucocorticoids / adverse effects. Glucocorticoids / therapeutic use. Humans. Middle Aged. Oligopeptides / therapeutic use. Peptides / therapeutic use. Plant Preparations / therapeutic use. Recurrence. Sarcoidosis, Pulmonary / drug therapy. Sarcoidosis, Pulmonary / immunology. Thorax. Thymus Extracts / therapeutic use. Vitamins / therapeutic use

  • Genetic Alliance. consumer health - Sarcoidosis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 11980125.001).
  • [ISSN] 0040-3660
  • [Journal-full-title] Terapevticheskiĭ arkhiv
  • [ISO-abbreviation] Ter. Arkh.
  • [Language] rus
  • [Publication-type] Clinical Trial; English Abstract; Journal Article
  • [Publication-country] Russia
  • [Chemical-registry-number] 0 / Adjuvants, Immunologic; 0 / Glucocorticoids; 0 / Oligopeptides; 0 / Peptides; 0 / Plant Preparations; 0 / Thymus Extracts; 0 / Vitamins; 0 / glikopin; 0 / thymohexin; 53678-77-6 / Acetylmuramyl-Alanyl-Isoglutamine; 89492-35-3 / T-activin
  •  go-up   go-down






Advertisement